Feline Mammary Tumors: The Cancer Most Cat Owners Don't Know About
Published estimates differ by case series, but feline mammary masses are far more likely to be malignant than comparable lumps in dogs, so prompt evaluation matters.
Typical Mammary Mass Workup Path
Finding
| Finding | Why It Raises Concern | Why Speed Matters | Typical Next Step |
|---|---|---|---|
| Pea-sized mammary lump | Even small masses may be malignant | Cats often do better when masses are addressed early | Prompt veterinary exam and staging discussion |
| Multiple nodules in chain | Could reflect spread within mammary tissue | Surgical planning may change | Discuss unilateral or bilateral chain surgery |
| Ulceration or discharge | Suggests locally aggressive disease or inflammation | Comfort and infection risk become issues too | Urgent evaluation |
| Unspayed or late-spayed history | Hormonal exposure influences risk | Important for risk context and prevention counseling | Review reproductive and medical history |
Mammary Tumor Response Rules
| Treat any new mammary lump as needing veterinary evaluation | |
| Ask about chest imaging and staging before or around surgery | |
| Expect histopathology to guide prognosis | |
| Use body handling at home to notice new changes early | |
| Discuss recurrence monitoring after treatment | |
| Assume a tiny lump is harmless because it is not painful | |
| Squeeze or repeatedly manipulate the mass at home | |
| Delay evaluation for weeks to see if it shrinks |
In cats, mammary masses deserve urgency. The most helpful owner action is not guessing what the lump is — it is shortening the time from detection to veterinary assessment.
Spaying is preventive, not curative. If a mass already exists, do not assume sterilization alone solves the problem; a full cancer workup may still be needed.
Mammary tumors are the third most common cancer in cats and the most common tumor in intact (unspayed) female cats. Critically, 85-93% of feline mammary tumors are malignant -- far higher than the roughly 50% malignancy rate in dogs. Early detection and prompt surgical excision are essential; the prognosis depends heavily on tumor size at time of surgery. Spaying before the first heat cycle reduces lifetime mammary cancer risk by 91%.
Why Malignancy Rates Are So High in Cats
In dogs, mammary tumor malignancy is roughly 50%. In cats, 85-93% of mammary tumors are malignant adenocarcinomas. The reason for this difference is not fully understood but may relate to the influence of progesterone receptors in feline mammary tissue and differences in tumor biology. Feline mammary adenocarcinomas are aggressive -- they invade locally, spread to regional lymph nodes, and metastasize to the lungs rapidly. A palpable mammary mass in a cat is malignant until proven otherwise. Any lump on the mammary chain warrants veterinary evaluation within days, not weeks.
Detection: Monthly Checks at Home
Cats have 8 mammary glands in two rows (4 per side). Early tumors are small, firm nodules that can be detected by palpation. Monthly chest-to-belly palpation along the mammary chain takes 30 seconds and can detect tumors when they are small enough that surgery is most effective. What to feel for: any firm, discrete nodule or thickening. Tumors in the inguinal (rear) glands are harder to feel; part the fur and check carefully. Male cats can develop mammary tumors (rarely); any mammary mass in a male is suspicious.
Diagnosis and Staging
Fine needle aspirate: cytology suggests malignancy but is not definitive for mammary carcinoma (low exfoliation in many feline carcinomas); surgical excision with histopathology is the definitive diagnostic and primary treatment. Staging: thoracic radiographs (3-view) for pulmonary metastases, abdominal ultrasound for regional lymph nodes, lymph node aspirate if enlarged. Tumor size at surgery is the strongest prognostic indicator: tumors less than 2 cm have median survival of 3 years; 2-3 cm have median survival of 15-24 months; tumors greater than 3 cm carry median survival of 4-6 months even with surgery.
Surgical Options
Regional or radical mastectomy is preferred over simple lumpectomy for feline mammary tumors. Radical mastectomy (removal of the entire mammary chain on one or both sides simultaneously) reduces local recurrence compared to removing individual tumors. This approach is supported by the biology: multicentric disease (multiple tumors in the same chain) is common. First surgery is the most important -- incomplete excision dramatically increases recurrence risk. Lymph node excision (inguinal and axillary nodes) is included in the procedure. Concurrent spay at surgery is recommended if not already done.
Chemotherapy and Prognosis
Doxorubicin-based chemotherapy is the most commonly used protocol for feline mammary carcinoma. Evidence for survival benefit is less robust than in canine osteosarcoma, but it is generally recommended for tumors with adverse histopathological features (lymphovascular invasion, high mitotic index, positive surgical margins). Cyclophosphamide is sometimes combined with doxorubicin. Overall prognosis for feline mammary carcinoma is guarded -- the high malignancy rate, tendency for early lymph node involvement, and pulmonary metastases make this a serious cancer. Prevention through early spaying is the most impactful intervention available.
Sources: Mammary tumor malignancy rates from Misdorp et al. (1999) WHO Classification of Mammary Tumors; spaying protective effect from Overley et al. (2005) JAVMA; tumor size prognosis from MacEwen et al. (1984) JAVMA; surgical outcomes from Novosad et al. (2006) JAVAHA; chemotherapy review from Poirier et al. (2004) JVIM.